Serina Therapeutics Wins NIH Funding

In the nation’s continuing battle to overcome opioid misuse and addiction, Huntsville’s Serina Therapeutics has won funding from the National Institutes of Health to support its research on a new one-dose painkiller for post-operative patients. The drug, SER-227, “is a polymer conjugate of buprenorphine that can be administered in the recovery room by a surgeon…

Thank you for reading!

To continue reading this article you must be registered and logged into this site. If you already have an account please login now, otherwise you can click here to register for new account. Registration is FREE.

Login       Register

The latest Alabama business news delivered to your inbox